Cyteir Therapeutics, Inc. announced the appointment of Krisztina Nemenyi, PhD, RAC, to its leadership team as Senior Vice President of Regulatory Affairs and Quality. Dr. Nemenyi is an experienced R&D regulatory leader with 20 years of experience across diverse organizations, regions, and responsibilities. She joins Cyteir from Takeda Pharmaceuticals, where she most recently served as VP, Global Program Lead for Oncology, ensuring successful registration of mobocertinib for the treatment of EGFR Exon 20 non-small cell lung cancer in the United States and United Kingdom.